{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:21:45Z","timestamp":1794313305473,"version":"4.9.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background and hypothesis<\/jats:title><jats:p>The presence of donor-specific anti-HLA antibodies before kidney transplantation (preDSAs) is associated with decreased graft survival. The hypothesis that increasing donor kidney age is negatively associated with the impact of preDSA on graft survival was investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Outcome of kidney transplantation in a single center cohort of 2,024 patients transplanted between 2010 and 2020 with a follow-up of at least 3 years was analyzed to assess this relation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>DSAs before transplantation were present in 14% of recipients and showed an independent association with graft loss. The preDSA against HLA class I (2%) or class II (7%) had an adjusted hazard ratio (HR) for death censored graft failure of 5.8 (95% CI 4.4\u20137.7), while the combination (5%) had an HR of 18.6 (95% CI 13.8\u201325.1). The preDSA-associated increase in graft failure was caused primarily by an increase in the incidence of antibody-mediated rejection (ABMR), intragraft thrombosis, and primary non-function. These effects were observed more frequently in the deceased donor kidney transplantations compared to living donor kidney transplantations. The incidence of ABMR was not associated with donor kidney age. However, increasing donor kidney age significantly aggravated the negative effect of preDSA on graft survival. For instance, recipients aged \u226565 years transplanted with a deceased donor kidney aged \u226565 years had an uncensored 1- and 3-year graft survival of 83% and 67%, respectively, if transplanted without DSA. This decreased to 56% and 35% if transplanted in the presence of DSA. For comparison, recipients aged \u226565 years of a deceased donor kidney aged &amp;lt;65 years had an uncensored 1- and 3-year graft survival of 92% and 78%, respectively, without preDSA, and if transplanted with preDSA, this decreased to 77% and 69%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The negative effect of circulating DSA at the time of transplantation on both early and late death-censored graft survival is heavily influenced by donor age.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1574324","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T05:28:03Z","timestamp":1744781283000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Increasing donor kidney age significantly aggravates the negative effect of pretransplant donor-specific anti-HLA antibodies on kidney graft survival"],"prefix":"10.3389","volume":"16","author":[{"given":"Michiel G. H.","family":"Betjes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Kal-van Gestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Roelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia M. L.","family":"Kho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Heidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies E.","family":"de Weerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"van de Wetering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5694670","DOI":"10.1155\/2020\/5694670","article-title":"Pretransplant donor-specific anti-HLA antibodies and the risk for rejection-related graft failure of kidney allografts","volume":"2020","author":"Betjes","year":"2020","journal-title":"J Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.13401118","article-title":"Preformed donor-specific HLA antibodies in living and deceased donor transplantation: A multicenter study","volume":"14","author":"Ziemann","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14709","article-title":"Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant","volume":"18","author":"Kamburova","year":"2018","journal-title":"Am J Transplant"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1093359","article-title":"The detrimental effect of donor-specific antibodies is irrespective of its level in highly-immunized living donor kidney transplant recipients: A case-control series","volume":"13","author":"Tramper","year":"2022","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31822dc38d","article-title":"Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch","volume":"92","author":"Higgins","year":"2011","journal-title":"Transplantation"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: a multicenter study","volume":"14","author":"Orandi","year":"2014","journal-title":"Am J Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000001006","article-title":"DSA in solid organ transplantation: is it a matter of specificity, amount, or functional characteristics","volume":"27","author":"Louis","year":"2022","journal-title":"Curr Opin Organ Transplant"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/tan.12537","article-title":"Inter-individual differences in HLA expression can impact the CDC crossmatch","volume":"85","author":"H\u00f6nger","year":"2015","journal-title":"Tissue Antigens"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/iji.12443","article-title":"Factors affecting HLA expression: A review","volume":"46","author":"Carey","year":"2019","journal-title":"Int J Immunogenetics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.110","article-title":"Premature aging of circulating T cells in patients with end-stage renal disease","volume":"80","author":"Betjes","year":"2011","journal-title":"Kidney Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1406716","article-title":"Older age is associated with a distinct and marked reduction of functionality of both alloreactive CD4+ and CD8+ T cells","volume":"15","author":"Litjens","year":"2024","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7903","DOI":"10.1038\/s41598-021-86943-3","article-title":"The FCGR3A 158 V\/V-genotype is associated with decreased survival of renal allografts with chronic active antibody-mediated rejection","volume":"11","author":"Litjens","year":"2021","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015080879","article-title":"Stretching the limits of renal transplantation in elderly recipients of grafts from elderly deceased donors","volume":"28","author":"Peters-Sengers","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13071853","article-title":"Transplant candidates of 70+ Years have superior survival if receiving pre-emptively a living donor kidney","volume":"13","author":"Betjes","year":"2024","journal-title":"J Clin Med"},{"key":"B17","article-title":"Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida","author":"Foley","year":"2005","journal-title":"Clin Transpl"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.01.043","article-title":"A nationwide evaluation of deceased donor kidney transplantation indicates detrimental consequences of early graft loss","volume":"97","author":"de Kok","year":"2020","journal-title":"Kidney Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13162","article-title":"Early graft loss after kidney transplantation: risk factors and consequences","volume":"15","author":"Hamed","year":"2015","journal-title":"Am J Transplant"},{"key":"B20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2020.12.005","article-title":"Early graft loss after deceased-donor kidney transplantation: what are the consequences","volume":"232","author":"Swinarska","year":"2021","journal-title":"J Am Coll Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the banff classification of renal allograft pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2021.07.005","article-title":"Alemtuzumab as second-line treatment for late antibody-mediated rejection of transplanted kidneys","volume":"53","author":"Betjes","year":"2021","journal-title":"Transplant Proc"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.842419","article-title":"Causes of kidney graft failure in a cohort of recipients with a very long-time follow-up after transplantation","volume":"9","author":"Betjes","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1104371","article-title":"Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study","volume":"14","author":"de Rougemont","year":"2023","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","year":"2009","journal-title":"Am J Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw445","article-title":"Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen","volume":"32","author":"Zecher","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15937","article-title":"Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report","volume":"20","author":"Tambur","year":"2020","journal-title":"Am J Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003203","article-title":"Creating options for difficult-to-match kidney transplant candidates","volume":"105","author":"de Klerk","year":"2021","journal-title":"Transplantation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"11112","DOI":"10.3389\/ti.2023.11112","article-title":"Increasing kidney-exchange options within the existing living donor pool with CIAT: A pilot implementation study","volume":"36","author":"de Klerk","year":"2023","journal-title":"Transpl Int"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004689","article-title":"Imlifidase desensitization in HLA-incompatible kidney transplantation: finding the sweet spot","volume":"108","author":"de Weerd","year":"2024","journal-title":"Transplantation"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181f65c7d","article-title":"The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome","volume":"252","author":"Tullius","year":"2010","journal-title":"Ann Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ajt.15672","article-title":"OPTN\/SRTR 2018 annual data report: kidney","author":"Hart","year":"2020","journal-title":"Am J Transplant"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1215167","article-title":"Lowering maintenance immune suppression in elderly kidney transplant recipients; connecting the immunological and clinical dots","volume":"10","author":"Betjes","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001680","article-title":"Risk stratification before living donor kidney transplantation in patients with preformed donor-specific antibodies by different crossmatch methods","volume":"10","author":"Ziemann","year":"2024","journal-title":"Transplant Direct"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1574324\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T05:28:04Z","timestamp":1744781284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1574324\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2025.1574324"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1574324","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1574324.s001","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"article-number":"1574324"}}